EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kidney biopsy during pregnancy: indications, complications, results, and therapeutic impact

Camille Imbert, Gaëlle Guettrot-Imbert, Julie Bruno, Stanislas Bataille iD, Mickaël Bobot iD, Sonia Boyet-Suavet, Florence Bretelle, Luca Campagni, Cécile Chauvet, Nathalie Costedoat-Chalumeau iD, Julien Dang, Adrien Flahault iD und 20 weitere

Nephrology Dialysis Transplantation · 18.05.2026

DOI: 10.1093/ndt/gfag108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 18.05.2026. Verfasst von Camille Imbert und 31 weiteren Autor:innen. Beteiligte Einrichtung: AP-HM, CHU Conception, Nephrology Department, Marseille, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GR2, GCLR, SFNDT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis The diagnosis of kidney disease can be challenging during pregnancy. A kidney biopsy (KB) may be proposed, but there is little recent data available to assess the risk/benefit ratio of this procedure during pregnancy.

Methods

In this French nationwide survey, we analysed the indications, complications, histological diagnoses, treatments, and obstetric outcomes of pregnant women who underwent native KB between 2006 and 2025.

Results

We gathered the medical records of 76 patients, with a median age of 29.5 [range 18–42] years, including two with twin pregnancies. KB was performed at a median gestational age of 13.5 [range 4–26] weeks. The main indications for KB were: nephrotic syndrome without acute kidney injury (AKI) (40.8%) and non-nephrotic proteinuria without AKI (40.8%). KB led to a diagnosis in 72 (94.7%) patients. The main histological diagnoses were lupus nephritis (43%), focal segmental glomerulosclerosis (13%), membranous nephropathy (13%), IgA nephropathy (12%), and idiopathic nephrotic syndrome consistent with minimal change disease (5%). One patient experienced bleeding requiring transfusion. Specific treatment was initiated in 48 (63.2%) patients after KB: corticosteroids (35.5%), hydroxychloroquine (27.6%), azathioprine (18.4%), calcineurin inhibitor (13.2%), rituximab (2.6%), and belimumab (1.3%). There was a high incidence of preeclampsia (16.4%), small for gestational age (21.3%) and intrauterine foetal death (9.0%) in this cohort. Preterm birth and low birth weight occurred in 65.0% and 56.7% of cases, respectively.

Conclusions

When considered necessary to establish a diagnosis during pregnancy, KB performed in the first two trimesters appears to be safe, with a high diagnostic yield and a significant impact on therapeutic decision-making and patient management.

Schlagwörter

Stichwörter der Autor:innen

chronic kidney diseaseglomerulonephritiskidney biopsylupus nephritispregnancysafety

Autor:innen und Institutionen

  • AP-HM, CHU Conception, Nephrology Department, Marseille, France.
  • AP-HP, Centre de Référence Maladies Auto-immunes et Systémiques Rares, Hôpital Cochin, Université de Paris, Paris, France.
  • Clinique Bouchard, Nephrology Department, Marseille, France.
  • Aix-Marseille Univ, C2VN, INSERM, INRAE, Marseille, France.
  • CHU Nice, Nephrology Department, Nice, France.
  • AP-HM, CHU Conception, Obstetrics Department, Marseille, France.

ORCID-Profile: Stanislas Bataille, Mickaël Bobot, Nathalie Costedoat-Chalumeau, Adrien Flahault, Sandrine Lemoine, Noémie Jourde-Chiche

Förderung

  • GR2
  • GCLR
  • SFNDT

Zitieren

APA

Imbert, C., Guettrot-Imbert, G., Bruno, J., Bataille, S., Bobot, M., Boyet-Suavet, S., Bretelle, F., Campagni, L., Chauvet, C., Costedoat-Chalumeau, N., Dang, J., Flahault, A., Gabilan, C., Gaible, C., Grunenwald, A., Guincestre, T., Hanrotel, C., Hanouna, G., Hummel, A., …, & Jourde-Chiche, N. (2026). Kidney biopsy during pregnancy: indications, complications, results, and therapeutic impact. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag108

Vancouver

Imbert C, Guettrot-Imbert G, Bruno J, Bataille S, Bobot M, Boyet-Suavet S, et al. Kidney biopsy during pregnancy: indications, complications, results, and therapeutic impact. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag108

BibTeX
@article{Imbert2026,
  author = {Imbert, Camille and Guettrot-Imbert, Gaëlle and Bruno, Julie and Bataille, Stanislas and Bobot, Mickaël and Boyet-Suavet, Sonia and Bretelle, Florence and Campagni, Luca and Chauvet, Cécile and Costedoat-Chalumeau, Nathalie and Dang, Julien and Flahault, Adrien and Gabilan, Charlotte and Gaible, Clotilde and Grunenwald, Anne and Guincestre, Thomas and Hanrotel, Catherine and Hanouna, Guillaume and Hummel, Aurélie and Kalbacher, Émilie and Lamy, Thomas and Guern, Véronique Le and Lemoine, Sandrine and Loundou, Anderson and Moussi, Julie and Pfirmann, Pierre and Tailliar, Maxence and Torrents, Julia and Zagdoun, Elie and Daniel, Laurent and Daugas, Eric and Jourde-Chiche, Noémie},
  title = {Kidney biopsy during pregnancy: indications, complications, results, and therapeutic impact},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfag108}
}
Kostenlos starten →